 |
|
Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
Yu Jung Jo, Kyung-Ah Kim, June Sung Lee, Nam-Hoon Kim, Won Ki Bae, Tae June Song, Jeong Wook Kim
Korean J Intern Med. 2015;30(2):170-176. Published online 2015 Feb 27 DOI: https://doi.org/10.3904/kjim.2015.30.2.170
|
|
Citations to this article as recorded by
 Chronic hepatitis B infection biochemical, virological and tissue treatment response in correlation with platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR) in Egyptian patients infected with chronic hepatitis B virus
Hesham H Elkilany, Sameh M Ghaly, Karim S Abdullah, Wesam E Wassfy, Nouran M Said
The Egyptian Journal of Haematology.2023; 48(4): 353. CrossRef Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients
Yan-Di Xie, Hui Ma, Bo Feng, Lai Wei
Chinese Medical Journal.2017; 130(18): 2190. CrossRef 5-year efficacy of entecavir in Indian patients with chronic hepatitis B
Gautam Ray
Indian Journal of Gastroenterology.2016; 35(3): 190. CrossRef
|